Clinical pharmacokinetics of pregabalin in healthy volunteers. - Wikidata - wikimedia - TriplyDB

Clinical pharmacokinetics of pregabalin in healthy volunteers.

Clinical pharmacokinetics of pregabalin in healthy volunteers.

http://www.wikidata.org/entity/Q43165981

about

Pregabalin for the treatment of generalized anxiety disorder: an update Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Pregabalin: a review of its use in adults with generalized anxiety disorder.Abuse Potential of Pregabalin: A Systematic Review.Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers.Comparative study between 2 different doses of pregabalin and lidocaine on pain following propofol injection: A double-blind, randomized clinical consort study.Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region.Pregabalin for the treatment of postsurgical pain.The use of newer antiepileptic drugs in patients with renal failure.Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.ADMET considerations for restless leg syndrome drug treatments.Pregabalin for alcohol dependence: a critical review of the literature.Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.Understanding the pharmacokinetics of anxiolytic drugs.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation.Spinal Reflexes and Windup In Vitro: Effects of Analgesics and Anesthetics.Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use.Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.Comparison of oral absorption models for pregabalin: usefulness of transit compartment model.The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women.A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults.NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity.Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effects.Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case report Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studies.Pregabalin for the management of neuropathic pain in spinal cord injury.Pregabalin abuse and dependence in Germany: results from a database query.Pregabalin abuse among opiate addicted patients.Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.The absorption profile of pregabalin in chronic pancreatitis.Pregabalin enhances the antinociceptive effect of oxycodone and morphine in thermal models of nociception in the rat without any pharmacokinetic interactions.

P2860

Q24604809-3D7A55AE-8103-4B0D-B76D-C7303E866948 Q26764876-C194B093-9EF3-458A-A01B-D13420E29AF3 Q34407163-9E86E5EF-4D17-4E73-9B62-A18E55824D12 Q34411257-771C1D6D-85C5-4B2C-82C4-98692EE3D6C2 Q34434641-3AAD186D-7754-4BFC-BFEE-C4ED66A70FE5 Q34509031-CFF6200A-91D7-4E81-8795-F554489E621B Q34613361-DD237F9A-542F-45BD-98FF-EE51880D8A07 Q34756216-7FD4F93C-A103-4FD6-9104-C091B154A32E Q35120597-71CB6EAF-4B37-4528-8009-E57FF8C1F0EB Q36252863-DB5F3319-D647-470C-8C48-50787C8D96C5 Q36443685-E2772F1E-6CBB-4221-86C4-68CE968EAD3F Q37530486-B8A0901C-495D-4A05-872B-226C782FFD0A Q37761937-F9EA38C7-816D-438C-9624-6C8DF1DB1437 Q37803241-D3424859-FCF5-42AB-8963-A1558C4F78A4 Q37965704-AA1F2829-051C-4F7C-A57E-6C05BBDA46E7 Q38025453-44AD2477-BE3F-4F94-825F-5F619B31C826 Q38027180-68CC150C-36AA-4D17-AFEB-E90DE46D8579 Q38058284-D92ACF59-9A5B-483C-A855-847AECAD536E Q38064486-A8E39CD2-B638-4BBB-8982-DA13980925F9 Q38075049-B4522C41-6689-4A8F-A025-ED1243ADF787 Q38152329-9A56D6C3-7D55-44F9-837D-D30578D18977 Q38242390-366D9E25-EFB2-4890-96D9-69D3CEA1C981 Q38537865-6BE92A5F-F1D8-4557-9D56-883F90990A66 Q38589027-E8AC0907-B4FF-47AD-A80C-FB09614DF1F3 Q38877302-92AFDE1E-74AC-4822-8C2F-1B493BE23169 Q39079619-B89BDD45-1392-4876-A248-2BAC957D098E Q39085683-F69C01FB-E21D-422B-ABDC-72310C3B583D Q39933211-130AC1D5-AC3D-4DFF-AD77-EE40AA40A9B0 Q40057939-FBA7A252-6195-4423-AD1A-9797C2DF7701 Q41960088-DB274625-DD13-413D-A509-B10455A0BF29 Q41992322-A3A00EC0-1A7F-4B0B-A02D-D148FB1369E2 Q42359905-D524BC04-F54E-4DF2-AB53-925246D8A0D7 Q42674842-A5E26616-E9A2-422C-93DB-D4AAA9E5A9F2 Q42674848-E6EC428A-78D1-499A-9605-4429E83CF55F Q43922422-DB62FE37-2C56-4411-9539-0C4461395EA7 Q44066305-8CD975D8-EA3E-41EA-B768-A6D0BCB3EF5E Q44236161-1944B810-8DF9-454E-9CC2-5E918EB970B7 Q45413391-662D6956-7443-4604-9E21-C9D945E0BB13 Q45720038-66C4CC3F-9FD4-45E0-8CA7-4DB30FBED892 Q47696003-BF4A1A63-E965-49A1-B2CA-6F8E4AE84270

P2860

Clinical pharmacokinetics of pregabalin in healthy volunteers.

http://www.wikidata.org/entity/Q43165981

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@en

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@nl

type

label

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@en

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@nl

prefLabel

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@en

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@nl

P1433

Q43165981-8172E5A0-B78E-4C28-A25F-CAA10FA94858

P1476

Q43165981-7878CF72-8457-4A75-9D8F-E99A71EAE738

P2093

Q43165981-03B74955-45E5-4EA5-B124-E8DB440F8D32

Q43165981-0424FE78-20CA-4B56-A852-0D667406F3AE

Q43165981-41D90166-0103-4F7C-B9F9-E62B9AA51C56

Q43165981-4C744470-EEE8-4122-9F88-92673CF48EE5

Q43165981-7632F49D-5F41-4194-8359-4D891DD334A4

Q43165981-8E40C8AC-3258-4DFA-A459-2AF4B662A9D1

Q43165981-96482F07-5E43-41CC-A246-26434F7CCA6B

Q43165981-A0CF7209-5270-4B2F-8684-04BC0388FB75

Q43165981-A6DFE65E-CCFF-4857-8CBE-DE508DA97651

Q43165981-E26C9844-448F-4FB2-85FB-E0FCDA2B63AA

P2860

Q43165981-06F39B0C-B164-4799-8BB6-388EDAA9C579

Q43165981-08F8585B-DA84-4709-9469-6AC599DE675D

Q43165981-09CF7DC1-F600-4466-8AB8-2ACAB2A6646E

Q43165981-0D2E464C-6B36-470F-9CED-0B4B487B82B6

Q43165981-16B25E5E-FE09-4361-BA8E-7DB9C5961F45

Q43165981-1B5D0B89-F97C-4C4E-AD84-3F1552312217

Q43165981-46A84AF2-E1F7-4356-BD63-195BD2845CAA

Q43165981-4C6A5F23-5F4D-47CA-B4EF-51FE35EF7935

Q43165981-55362894-BC88-4A98-82A8-3F24DF054FEC

Q43165981-56C9A658-943E-47B7-8DC2-8EEA48E9F9EB

P304

Q43165981-C2F86F59-783E-4320-A3FE-9FD2B789041E

P31

Q43165981-48843CFA-230B-459D-AB96-7D5A6513E12C

P356

Q43165981-0A259F48-B7E0-4FF1-978C-E0F6B763F8FE

P433

Q43165981-6DCA8120-9517-4038-9FE6-A8D8DF51D9CD

P478

Q43165981-2C5CC669-2C0E-4D3C-BF98-807F7838A529

P577

Q43165981-C81F0EE9-FEC8-4B99-A4A7-27583F3CE165

P698

Q43165981-E185A53A-EBAD-4C64-B56B-BD2930931AA8

P356

0091270009352087

P1433

The Journal of Clinical Pharmacology

P1476

Clinical pharmacokinetics of pregabalin in healthy volunteers.

@en

P2093

Brian W Corrigan

http://www.w3.org/2001/XMLSchema#string

Christine W Alvey

http://www.w3.org/2001/XMLSchema#string

David L Wesche

http://www.w3.org/2001/XMLSchema#string

Edward J Randinitis

http://www.w3.org/2001/XMLSchema#string

Edward L Posvar

http://www.w3.org/2001/XMLSchema#string

George M Haig

http://www.w3.org/2001/XMLSchema#string

Howard N Bockbrader

http://www.w3.org/2001/XMLSchema#string

James C Strand

http://www.w3.org/2001/XMLSchema#string

Janice A Busch

http://www.w3.org/2001/XMLSchema#string

Louis L Radulovic

http://www.w3.org/2001/XMLSchema#string

P2860

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Effects of food on clinical pharmacokinetics.

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

P304

941-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270009352087

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20147618

http://www.w3.org/2001/XMLSchema#string